Short Interest in ProPhase Labs, Inc. (NASDAQ:PRPH) Declines By 25.2%

ProPhase Labs, Inc. (NASDAQ:PRPH) was the recipient of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 154,100 shares, a drop of 25.2% from the October 15th total of 206,100 shares. Based on an average daily trading volume, of 83,200 shares, the days-to-cover ratio is currently 1.9 days.

ProPhase Labs Price Performance

PRPH opened at $0.75 on Friday. The business has a 50 day moving average of $2.20 and a 200-day moving average of $3.29. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.58 and a quick ratio of 1.44. ProPhase Labs has a 1-year low of $0.66 and a 1-year high of $7.48.

ProPhase Labs (NASDAQ:PRPH) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.25). The company had revenue of $2.47 million during the quarter. ProPhase Labs had a negative net margin of 217.64% and a negative return on equity of 60.20%. On average, equities analysts expect that ProPhase Labs will post -1.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in ProPhase Labs stock. Vanguard Group Inc. lifted its holdings in shares of ProPhase Labs, Inc. (NASDAQ:PRPH) by 1.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 618,763 shares of the company’s stock after acquiring an additional 9,416 shares during the period. Vanguard Group Inc. owned approximately 3.43% of ProPhase Labs worth $4,003,000 as of its most recent filing with the SEC. 9.45% of the stock is currently owned by hedge funds and other institutional investors.

ProPhase Labs Company Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.